Phenotypic similarity for rare disease: Ciliopathy diagnoses and subtyping.


Journal

Journal of biomedical informatics
ISSN: 1532-0480
Titre abrégé: J Biomed Inform
Pays: United States
ID NLM: 100970413

Informations de publication

Date de publication:
12 2019
Historique:
received: 01 04 2019
revised: 05 09 2019
accepted: 11 10 2019
pubmed: 18 10 2019
medline: 21 10 2020
entrez: 18 10 2019
Statut: ppublish

Résumé

Rare diseases are often hard and long to be diagnosed precisely, and most of them lack approved treatment. For some complex rare diseases, precision medicine approach is further required to stratify patients into homogeneous subgroups based on the clinical, biological or molecular features. In such situation, deep phenotyping of these patients and comparing their profiles based on subjacent similarities are thus essential to help fast and precise diagnoses and better understanding of pathophysiological processes in order to develop therapeutic solutions. In this article, we developed a new pipeline of using deep phenotyping to define patient similarity and applied it to ciliopathies, a group of rare and severe diseases caused by ciliary dysfunction. As a French national reference center for rare and undiagnosed diseases, the Necker-Enfants Malades Hospital (Necker Children's Hospital) hosts the Imagine Institute, a research institute focusing on genetic diseases. The clinical data warehouse contains on one hand EHR data, and on the other hand, clinical research data. The similarity metrics were computed on both data sources, and were evaluated with two tasks: diagnoses with EHRs and subtyping with ciliopathy specific research data. We obtained a precision of 0.767 in the top 30 most similar patients with diagnosed ciliopathies. Subtyping ciliopathy patients with phenotypic similarity showed concordances with expert knowledge. Similarity metrics applied to rare disease offer new perspectives in a translational context that may help to recruit patients for research, reduce the length of the diagnostic journey, and better understand the mechanisms of the disease.

Identifiants

pubmed: 31622800
pii: S1532-0464(19)30228-X
doi: 10.1016/j.jbi.2019.103308
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103308

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Xiaoyi Chen (X)

INSERM UMR1138, Centre de Recherche des Cordeliers, Team 22, Paris, France. Electronic address: xiaoyi.chen@inserm.fr.

Nicolas Garcelon (N)

Institut Imagine, Paris Descartes University-Sorbonne Paris Cité, Paris, France.

Antoine Neuraz (A)

INSERM UMR1138, Centre de Recherche des Cordeliers, Team 22, Paris, France; Department of Medical Informatics, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.

Katy Billot (K)

INSERM UMR1163, Institut Imagine, Laboratory of Inherited Kidney Diseases, Paris, France; Paris Descartes University Sorbonne Paris Cité, Paris, France.

Marc Lelarge (M)

INRIA-ENS, Paris, France.

Thomas Bonald (T)

Telecom ParisTech, Paris, France.

Hugo Garcia (H)

INSERM UMR1163, Institut Imagine, Laboratory of Inherited Kidney Diseases, Paris, France; Paris Descartes University Sorbonne Paris Cité, Paris, France.

Yoann Martin (Y)

INSERM UMR1163, Institut Imagine, Laboratory of Inherited Kidney Diseases, Paris, France; Paris Descartes University Sorbonne Paris Cité, Paris, France.

Vincent Benoit (V)

Institut Imagine, Paris Descartes University-Sorbonne Paris Cité, Paris, France.

Marc Vincent (M)

Institut Imagine, Paris Descartes University-Sorbonne Paris Cité, Paris, France.

Hassan Faour (H)

Institut Imagine, Paris Descartes University-Sorbonne Paris Cité, Paris, France.

Maxime Douillet (M)

Institut Imagine, Paris Descartes University-Sorbonne Paris Cité, Paris, France.

Stanislas Lyonnet (S)

INSERM UMR1163, Institut Imagine, Laboratory of Embryology and Genetics of Congenital Malformations, Paris, France; Paris Descartes University Sorbonne Paris Cité, Paris, France; Department of Genetics, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.

Sophie Saunier (S)

INSERM UMR1163, Institut Imagine, Laboratory of Inherited Kidney Diseases, Paris, France; Paris Descartes University Sorbonne Paris Cité, Paris, France.

Anita Burgun (A)

INSERM UMR1138, Centre de Recherche des Cordeliers, Team 22, Paris, France; Department of Medical Informatics, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Paris Descartes University Sorbonne Paris Cité, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH